Skip to main content
Premium Trial:

Request an Annual Quote

LifeCodexx to Expand Lab for Trisomy 21 Test

Premium

LifeCodexx of Konstanz, Germany, will expand its laboratory next year to provide sequencing capacity for its upcoming non-invasive prenatal diagnostic test for trisomy 21, its parent company GATC Biotech said last week.

This summer, LifeCodexx licensed a patent surrounding technology for the test from Sequenom. Under the five-year agreement, the companies will develop and launch next-gen sequencing-based tests to diagnose trisomy 21 and possibly other aneuploidies in Germany, Austria, Switzerland, and Lichtenstein first, and maybe in other countries later (CSN 8/17/2011).

In June, LifeCodexx said that it started a clinical validation study of the trisomy 21 test, involving 500 samples analyzed on the Illumina HiSeq 2000. At the time, it was planning to launch the test by the end of this year (CSN 6/29/2011).

Sequenom started offering its MaterniT21 Down syndrome test as a lab-developed test in 20 metropolitan areas in the US last month (CSN 10/19/2011).

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.